Skip to content

Hemodynamic monitoring and postoperative management using Vigileo (SVV) for high risk patient during neurosurgery

Hemodynamic monitoring and postoperative management using Vigileo (SVV) for high risk patient during neurosurgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003583
Enrollment
Unknown
Registered
2013-08-20
Start date
2013-08-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient of neurosurgery

Interventions

the trial group:goal direct treatment through SVV and CI come from Vigileo
control group:According to the experience of treatment capacity

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. all the neurosurgery patients in West China Hospital will be involved in our study; 2. At least one of below characteristics: (1) The length of operation is more than 120 mins; (2) Blood loss more than 800 ml during the surgery; (3) Have at least one of below complications: 1) Ischemic heart disease or Heart function classification (NYHA) more than III; 2) Moderate or severe chronic obstructive pulmonary disease (COPD); 3) aged more than 70 yrs; 4) American Standards Association classification (ASA) more than 3 degree, or chronic renal insufficiency and diabetes mellitus.

Exclusion criteria

Exclusion criteria: 1. arrhythmia; 2. weight less than 55 kg or above 140 kg; 3. the age under 18 years of age.

Design outcomes

Primary

MeasureTime frame
P-POSSUM scoring at the postoperative 8 hrs and 24 hrs for mortality prediction in general neurosurgery;Calculate the ratio of complication morbility and mortality based on the formula.;All the complications, including cardiac, pulmonary, renal, gastrointestinal complications and thrombosis.;Length of hospital stay and ICU stay;Mortality of the patients;Mortality of the patients ;

Secondary

MeasureTime frame
Arterial and venous blood gas analysis every one hour during the surgery and at 4 hrs, 8 hrs and 24 hrs after surgery;The type and the volume of fluid, including RBC, plasma, platelet, crystoloid solution and colloid fluid during the surgery and at 8 hrs after surgery.;

Countries

China

Contacts

Public ContactGuo Chen

West China Hospital, Sichuan University

grace_chenguo@hotmail.com+86 18980601577

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 8, 2026